EXTON, Pa.--(BUSINESS WIRE)--Adolor Corporation (Nasdaq: ADLR) announced today that GlaxoSmithKline (GSK) has returned to Adolor worldwide rights related to Entereg® (alvimopan) for chronic opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback